Therapeutic Asset Ratings
172 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
MIDAZOLAM
Acute Lymphoblastic Leukemia
Kura Oncology, Inc.
P1/2
CC
(41)
mk-1045
Acute Lymphoblastic Leukemia
MSD R&D (China) Co., Ltd.
P1/2
CC
(41)
Osimertinib
Acute Lymphoblastic Leukemia
Syndax Pharmaceuticals
P1/2
CC
(41)
Ziftomenib
Acute Lymphoblastic Leukemia
Tanja Andrea Gruber
P1/2
CC
(41)
Γδ T Cells
Acute Lymphoblastic Leukemia
Chinese PLA General Hospital
P1/2
CC
(41)
CIS-DIAMMINEDICHLOROPLATINUM II
Acute Lymphoblastic Leukemia
City of Hope Medical Center
P1
CC
(40)
Letrozole
Acute Lymphoblastic Leukemia
Hospital General de Mexico
P1
CC
(40)
Prgn-3007
Acute Lymphoblastic Leukemia
H. Lee Moffitt Cancer Center and Research Institute
P1
CC
(40)
Bpx-501 T Cells
Acute Lymphoblastic Leukemia
Bellicum Pharmaceuticals
P1/2
CC
(40)
Actinium Ac 225-Dota-Daratumumab
Acute Lymphoblastic Leukemia
City of Hope Medical Center
P1
C
(37)
Allodepleted T Cells
Acute Lymphoblastic Leukemia
Baylor College of Medicine
P1
C
(37)
arm011
Acute Lymphoblastic Leukemia
TriArm Therapeutics (Taiwan) Limited
P1
C
(37)
Bleximenib
Acute Lymphoblastic Leukemia
Janssen Research & Development, LLC
P1
C
(37)
CD19.CAR-multiVSTs
Acute Lymphoblastic Leukemia
Baylor College of Medicine
P1
C
(37)
cd19+cd22 car t-cells
Acute Lymphoblastic Leukemia
University College, London
P1
C
(37)
cd22 car-t
Acute Lymphoblastic Leukemia
Rong Tao
P1
C
(37)
DARATUMUMAB
Acute Lymphoblastic Leukemia
City of Hope Medical Center
P1
C
(37)
Eagd T-Cell Infusion
Acute Lymphoblastic Leukemia
University of Kansas Medical Center
P1
C
(37)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center
P1
C
(37)
fxs0683
Acute Lymphoblastic Leukemia
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
P1
C
(37)
Gnc-038
Acute Lymphoblastic Leukemia
Sichuan Baili Pharmaceutical Co., Ltd.
P1
C
(37)
Hucart19-Il18
Acute Lymphoblastic Leukemia
University of Pennsylvania
P1
C
(37)
Human Cd19-Cd22 Targeted T Cells
Acute Lymphoblastic Leukemia
Hrain Biotechnology Co., Ltd.
P1
C
(37)
ic9-car19 t cells
Acute Lymphoblastic Leukemia
UNC Lineberger Comprehensive Cancer Center
P1
C
(37)
Icaspase9-Transduced T Cells
Acute Lymphoblastic Leukemia
Baylor College of Medicine
P1
C
(37)
Showing 126 to 150 of 172 assets
Previous
Page 6 of 7
Next